135 related articles for article (PubMed ID: 38593384)
21. Fluorodeoxyglucose versus Non-Fluorodeoxyglucose PET-Computed Tomography in Less-Explored Domains: An Appraisal.
Basu S; Kumar R; Alavi A
PET Clin; 2022 Jul; 17(3):xv-xvi. PubMed ID: 35717107
[No Abstract] [Full Text] [Related]
22. Response to treatment in a patient with gouty arthritis and tophi evaluated by fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography.
Treglia G; Giovanella L; Muoio B; Bertagna F
J Clin Rheumatol; 2014 Jun; 20(4):233-4. PubMed ID: 24847753
[No Abstract] [Full Text] [Related]
23. Sequential 18F-fluorodeoxyglucose positron emission tomography imaging in cardiac sarcoidosis.
Sperry BW; Vuppala S
J Nucl Cardiol; 2024 May; 35():101860. PubMed ID: 38583507
[No Abstract] [Full Text] [Related]
24. Letter from the editors: positron emission tomography radiopharmaceuticals-current status.
Freeman LM; Blaufox MD
Semin Nucl Med; 2011 Jul; 41(4):243. PubMed ID: 21624558
[No Abstract] [Full Text] [Related]
25. Fluorodeoxyglucose-positron emission tomography imaging characteristics of unusual cystic metastasis on the liver surface arising from gallbladder carcinoma.
Basu S; Rao R
Jpn J Radiol; 2009 May; 27(4):194-6. PubMed ID: 19499311
[No Abstract] [Full Text] [Related]
26. Serial
Lamacie MM; Almufleh A; Nair V; Stadnick E; Birnie D; Beanlands RSB; Chih S
Circ Cardiovasc Imaging; 2020 Feb; 13(2):e009940. PubMed ID: 32000512
[No Abstract] [Full Text] [Related]
27. Incidental detection of acute lymphoblastic leukemia on [18F]fluorodeoxyglucose positron emission tomography.
Ennishi D; Maeda Y; Niiya M; Shinagawa K; Tanimoto M
J Clin Oncol; 2009 Dec; 27(36):e269-70. PubMed ID: 19826118
[No Abstract] [Full Text] [Related]
28. Diagnosis of myocardial abscess secondary to infective endocarditis by
López-Aguilera J; López-Granados A; Mesa-Rubio D
Med Clin (Barc); 2017 Feb; 148(4):e21-e22. PubMed ID: 28038859
[No Abstract] [Full Text] [Related]
29. Intraductal papillary neoplasm of bile duct detected on fluorodeoxyglucose-positron emission tomography performed for cancer scanning.
Inoue H; Isaji S; Takei Y
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):e71. PubMed ID: 19559815
[No Abstract] [Full Text] [Related]
30.
Ederhy S; Devos P; Pinna B; Funck-Brentano E; Abbar B; Fenioux C; Cohen AA; Moslehi J; Bretagne M; Allenbach Y; Kharroubi D; Salem JE
Arch Cardiovasc Dis; 2022 Feb; 115(2):114-116. PubMed ID: 35120869
[No Abstract] [Full Text] [Related]
31. Mismatch of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and Tc-99m pertechnetate thyroid scan in subacute thyroiditis.
Lambert M; Jouret F; Lonneux M; Jamar F
Acta Clin Belg; 2008; 63(3):209-10. PubMed ID: 18714854
[No Abstract] [Full Text] [Related]
32. Preliminary experience of 18F-fluorodeoxyglucose positron emission tomography in Castleman's disease.
Robinson H; Prince HM; Ramdave S; Seymour JF; Elliott P; Hicks R
Leuk Lymphoma; 2006 Dec; 47(12):2664-6. PubMed ID: 17169817
[No Abstract] [Full Text] [Related]
33. Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations.
Heinen FJ; Tanis W
Eur Heart J; 2022 Sep; 43(35):3369. PubMed ID: 35706392
[No Abstract] [Full Text] [Related]
34. Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer from Ontario and guidelines in general--some observations.
Wong WL; Ross P; Corcoran M
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):242-5. PubMed ID: 23422786
[No Abstract] [Full Text] [Related]
35. Diagnosis of extensive myocardial infiltration by diffuse large B-cell lymphoma using 18F-fluorodeoxyglucose positron emission tomography (18-FDG PET).
Higgins AY; Taylor EP; Baldassarre LA; Miller EJ; Rosenfeld LE
J Nucl Cardiol; 2018 Oct; 25(5):1869-1871. PubMed ID: 29116563
[No Abstract] [Full Text] [Related]
36. Adult-onset Still disease: evaluation with serial f-18 fluorodeoxyglucose positron emission tomography.
Vranken E; Versijpt J; Winne L; Veys EM; Hamphrey H
Clin Nucl Med; 2005 Nov; 30(11):740-1. PubMed ID: 16237300
[No Abstract] [Full Text] [Related]
37. [Positron emission tomography (PET) in gastrointestinal cancer].
Montravers F; Grahek D; Kerrou K; Gutman F; Talbot JN
Gastroenterol Clin Biol; 2006 May; 30(5):737-41. PubMed ID: 16801895
[No Abstract] [Full Text] [Related]
38. Positron Emission Tomography in Atherosclerosis Research.
Roivainen A; Ståhle M; Saraste A
Methods Mol Biol; 2022; 2419():825-839. PubMed ID: 35238004
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating lung cancer recurrence.
Asai N; Ohkuni Y; Shoji K; Kaneko N
J Bras Pneumol; 2013; 39(2):242-4. PubMed ID: 23670511
[No Abstract] [Full Text] [Related]
40. Clinical Impact of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Carried Out for Non-Medicare Eligible Indications in Australia: A Prospective Study.
Lin P; Stoakes E; Scott A; Sam S; Chicco A
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):753-4. PubMed ID: 26345249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
